Foghorn Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | 926.7 | 678.8 | 396.2 | 599.7 | 641.9 | 127.0 | 61.6 | 22.7 | 13.9 | 12.6 | 13.5 | 6.5 | 8.0 | 8.4 | 8.5 | 22.8 | 13.0 | 9.9 | 12.2 | 12.6 | 11.0 | 11.8 | 9.4 | |
| – | – | – | – | – | – | – | – | – | – | – | 2.7 | 3.9 | 3.8 | 6.3 | 8.7 | 8.7 | 11.9 | 14.7 | 2,388.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 765.9 | 621.7 | 297.4 | 563.6 | 570.5 | 85.1 | 55.6 | 17.6 | 11.5 | 10.4 | 11.2 | 4.6 | 5.9 | 6.3 | 4.8 | 20.9 | 11.0 | 7.7 | 9.5 | 9.2 | 8.4 | 8.7 | 7.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.6 | 2.4 | 1.5 | 1.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -11.9% | -12.5% | -16.6% | -16.2% | -6.3% | 38.6% | 41.3% | 65.1% | 71.9% | -42.7% | -38.9% | -57.6% | -43.4% | -41.1% | -36.7% | -17.8% | -34.4% | -41.2% | -30.9% | -28.8% | -25.3% | -26.2% | -24.7% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | -21,492.7% | -5,875.3% | -4,497.3% | -3,712.2% | -6,717.4% | -5,989.8% | -1,638.5% | -919.6% | -533.8% | -449.3% | -293.4% | -288.4% | -157.0% | -65.0% | -66.2% | 23.0% | 96.7% | 100.0% | 100.0% | 96.3% | 14.7% | 29.8% | 22.3% | 42.7% | |
| – | – | – | – | – | – | – | – | – | – | -35,160.9% | -15,937.4% | -10,885.1% | -8,608.9% | -10,902.1% | -7,637.1% | -2,128.2% | -1,214.9% | -719.3% | -609.2% | -594.9% | -577.7% | -351.0% | -315.9% | -303.2% | -276.7% | -408.1% | -454.3% | -414.4% | -380.0% | -352.9% | -265.6% | -286.2% | -186.4% | |
| – | – | – | – | – | – | – | – | – | – | -35,382.1% | -16,000.0% | -10,870.7% | -8,565.0% | -10,844.2% | -7,681.6% | -2,124.9% | -1,194.3% | -692.6% | -566.3% | -545.5% | -527.6% | -316.9% | -288.2% | -274.2% | -245.7% | -357.5% | -383.2% | -342.2% | -311.9% | -294.2% | -240.3% | -266.9% | -175.8% | |
| – | – | – | – | – | – | – | – | – | – | -23,819.6% | -11,039.3% | -8,467.5% | -6,580.5% | -9,744.3% | -4,060.9% | 4,899.4% | 2,542.4% | 1,481.2% | 1,000.6% | -536.9% | -524.6% | -371.3% | -349.4% | -345.1% | -312.3% | -407.2% | -448.2% | -407.9% | -377.8% | -362.5% | -278.7% | -309.7% | -232.3% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | -116.5% | – | – | – | – | -320.5% | – | -47.1% | -62.2% | -81.8% | -114.8% | -104.6% | -145.4% | -229.8% | -448.7% | -97,216.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -228.8% | – | -61.6% | -44.5% | -26.9% | -33.9% | -40.9% | -49.9% | -19.5% | -21.6% | -24.0% | -25.2% | -26.9% | -30.2% | -33.8% | -32.9% | -34.4% | -36.5% | -26.3% | -29.6% | -30.5% | -31.1% | -33.3% | -35.2% | -37.5% | -33.9% | -31.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | 1.5 | – | -21 | -60 | -69 | -41 | -98 | -31 | -94 | -208 | -56 | -81 | -46 | -44 | -50 | -62 | -72 | -71 | -131 | -49 | -46 | -52 | -66 | -83 | -80 | -87 | -65 | |
| – | – | – | – | – | – | – | -393.9% | – | 19.2% | -93.6% | 57.2% | 54.4% | 50.0% | 43.5% | 18.6% | 14.8% | 10.4% | 5.6% | 0.0% | -6.6% | -14.5% | -18.3% | -27.0% | -38.2% | -4.4% | -9.2% | -16.0% | -23.8% | -33.9% | -43.7% | -54.8% | -34.4% | -39.8% | |
| – | – | – | – | – | – | – | – | – | 0.9 | – | 0.2 | 0.2 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.3 | 53.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -1.66 | -9.69 | -10.93 | -2.20 | -2.31 | -2.43 | -2.62 | -1.77 | -3.50 | -2.11 | -2.31 | -2.51 | -2.74 | -2.54 | -2.64 | -2.62 | -2.60 | -2.69 | -2.74 | -2.46 | -2.33 | -2.19 | -1.68 | -1.46 | -1.38 | -1.28 | -1.20 | -1.14 | -1.18 | -1.08 | -0.91 | |
| – | – | – | – | – | – | – | – | – | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.04 | 0.12 | 0.22 | 0.38 | 0.46 | 0.49 | 0.52 | 0.77 | 0.81 | 0.80 | 0.68 | 0.41 | 0.36 | 0.37 | 0.38 | 0.39 | 0.49 | 0.41 | 0.52 | |
| – | – | – | – | 8.31 | – | – | -3.98 | -0.06 | 0.82 | -3.74 | 7.45 | 3.40 | 2.83 | 2.19 | 2.62 | 1.75 | 1.15 | 0.58 | 0.00 | -0.59 | -1.18 | -1.37 | -1.83 | -2.30 | -0.28 | -0.45 | -0.73 | -0.98 | -1.22 | -1.42 | -1.72 | -1.10 | -1.15 | |
| – | – | – | -1.53 | -9.02 | -10.26 | -2.07 | -2.14 | -2.18 | -2.36 | -1.19 | -2.42 | -1.65 | -1.78 | -2.26 | -1.45 | 5.87 | 5.61 | 5.60 | 4.60 | -2.65 | -2.72 | -2.88 | -2.82 | -2.76 | -2.13 | -1.66 | -1.62 | -1.53 | -1.45 | -1.41 | -1.37 | -1.26 | -1.21 | |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.